Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Journal of Medical Genetics

Volumn 40, Issue 11, 2003, Pages 807-814

  Amir, E ^b   Evans, D G ^a   Shenton, A ^a   Lalloo, F ^a   Moran, A ^b   Boggis, C ^c   Wilson, M ^c   Howell, A ^d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; ROC CURVE; STATISTICAL SIGNIFICANCE;

EID: 0344442208     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.11.807     Document Type: Article

References (18)

1. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Milvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
2. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541-48.
3. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer: implications for risk prediction. Cancer 1994;73:643-51.
4. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, the Breast Cancer Linkage Consortium. Risk of cancer in BRCA-1 mutation carriers. Lancet 1994;343:692-5.
5. Euhus DM. Understanding mathematical models for breast cancer risk assessment and counselling. Breast J 2001;7:224-32.
6. Tyrer JP, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med (in press).
7. IBIS investigators. First results from the International Breast Cancer Intervention Study (IBIS-1): a randomised prevention trial. Lancet 2002;360:817-24.
8. Evans DGR, Fentiman IS, McPherson K, Asbury D, Ponder BAJ, Howell A. Familial breast cancer. BMJ 1994;308:183-7.
9. Evans DGR, Lalloo F. Risk assessment and management of hereditary breast cancer. J Med Genet 2002;39:865-71.
10. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676-89.
11. Harrell FE, Lee KL, Pollock BG. Regression models in clinical studies; determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198-202.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
13. Euhus DM, Leitch AM, Huth JF, Peters GN. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast 2002;8:23-7.
14. McTiernan A, Kuniyuki A, Yasui Y, Bowen D, Burke W, Culver JB, Anderson R, Durfy S. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:333-8.
15. Tischkowitz M, Wheeler D, France E, Chapman C, Lucassen A, Sampson J, Harper P, Krawczak M, Gray J. A comparison of methods currently used in clinical practice to estimate familial breast cancer risks. Ann Oncol 2000;11:451-4.
16. Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 1999;354:1846-50.
17. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. Weighing the risks and benefits of tamoxifen treatment far preventing breast cancer. J Natl Cancer Inst 1999;91:1829-46.
18. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66.